Compare BridgeBio Pharma Inc (BBIO) vs Box Inc (BOX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Box Inc — how do they compare? BridgeBio Pharma Inc trades at $83.86 (market cap $16.36B), while Box Inc trades at $32.59 (market cap $4.55B). The key difference: BridgeBio Pharma Inc is far larger — about 3.6× Box Inc's market cap. Which is the better fit depends on your goals.
| BBIO | BOX | |
|---|---|---|
Market Cap | $16.36B | $4.55B |
Sector | Health | Technology |
52-Week High | $90.17 | $33.60 |
52-Week Low | $47.29 | $21.37 |
Enterprise Value | $18.14B | $5.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →
